Efficiency of rehabilitation treatment of patients with post-COVID syndrome

Along with the obvious clinical symptoms caused by the reactivity of the cytokine storm syndrome, patients experience extrapulmonary manifestations of COVID-19. A thorough analysis of large arrays of patients showed that residual symptoms in people with microbiological normalization (i. e., with negative results of the SARS-CoV-2 virus as a criterion for the effectiveness of etiotropic treatment) represent a complex of clinical manifestations that have a single etiopathogenesis, and thus the following is formed concept as post-covid syndrome. Post-covid syndrome has become one of the leading consequences of a new coronavirus infection. The physical, cognitive and neuropsychological consequences of the disease are increasingly becoming realistic, and the associated functional limitations may persist long after discharge from the hospital, negatively affecting the quality of life of patients. Modern ideas of a number of foreign scientists about the manifestations and pathogenesis of post-covid syndrome are reduced to the following aspects: symptoms caused by persistent chronic inflammation are combined with the consequences of damage to internal organs and non-specific manifestations of hospitalization and social isolation. One of the evidence of the pathogenesis of post-covid syndrome is the change in biomarkers, which are criteria for impaired cognitive-motor and psycho-cognitive states of coronavirus infection. The article analyzes the practical experience of using programs for the rehabilitation treatment of patients with COVID-19 in outpatient medical organizations, taking into account changes and prediction of further development of post-COVID syndrome based on the dynamics of concentrations of patients' blood biomarkers. Comprehensive rehabilitation treatment of patients with COVID-19, based on the individual selection of not only physical and physiotherapeutic treatment regimens, but also on the use of drugs, especially drugs that stimulate regeneration and repair, will help to avoid many of the negative consequences of the pathology.

1. Tenforde M. W. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network — United States, March-June 2020 // MMWR Morb Mortal Wkly Rep. 2020; 69 (30): 993-998.

2. De Biase S., Cook L., Skelton D. A., Witham M., ten Hove R. The COVID19 rehabilitation pandemic. Age Ageing, 2020.

3. Bartlo P., Bauer N. Pulmonary Rehabilitation Post-Acute Care for Covid-19 (PACER) // Available at: https://youtu.be/XjY_7O3Qpd8_accessed 11.05.2020.

4. Klok F. A., Boon G. J. A. M., Barco S., et al. The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19 // Eur Respir J. 2020; 56: 2001494. [https://doi.org/10.1183/13993003.014942020].

5. Steardo L., Steardo L. Jr., Zorec R., et al. Neuroinfection may contribute to pathophysiology and clinical manifestations of COVID-19 // Acta Physiol. 2020; 229: e13473. DOI: 10.1111/apha.13473.

6. Carfì A., Bernabei R., Landi F. Persistent symptoms in patients after acute COVID-19 // JAMA. 2020; 324 (6): 603-605.

7. Li Y., Li H., Fan R., et al. Coronavirus infections in the central nervous system and respiratory tract show distinct features in hospitalized children // Intervirology. 2016; 59 (3): 163-169.

8. Li Y. C., Bai W. Z., Hirano N., et al. Neurotropic virus tracing suggests a membranous-coating-mediated mechanism for transsynaptic communication // J Comp Neurol. 2013; 521 (1): 203-212.

9. Huang C., Wang Y., Li X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [published correction appears in Lancet. 2020 Jan 30] // Lancet. 2020; 395 (10223): 497-506.

10. Kress J. P., Hall J. B. ICU-acquired weakness and recovery from critical illness // N Engl J Med. 2014; 370 (17): 1626-1635.

11. Garg P., Arora U., Kumar A., Wig N. The «postCOVID» syndrome: how deepis the damage? // J Med Virol. 2020. https://doi.org/10.1002/jmv.26465.

12. Prevention, diagnosis and treatment of novel coronavirus infection (COVID-19). Temporary guidelines. Version 9. (26.10.2020). MZ RF. Р. 236.]

13. Pathological anatomy of the lungs in COVID-19. Atlas / Pod red. O. V. Zayrat'yantsa. Ryazan': Izd-vo GUP Ryazanskaya oblastnaya tipografiya, 2020. p 52., 62 il.

14. Benussi A., Pilotto A., Premi E., et al. Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy [published online ahead of print, 2020 May 22]. Neurology. 2020; 10.1212/WNL.0000000000009848.

15. Talevi D., Socci V., Carai M., et al. Mental health outcomes of the CoViD-19 pandemic // Riv. Psichiatr. 2020; 3 (55): 137-144.

16. WHO Media Center 2021: Epidemiological and Operational updates. WHO reference number: WHO/2019-nCoV/clinical/2020.5.

17. Pietrobelli A., Pecoraro L., Ferruzzi A., et al. Effects of COVID-19 lockdown on lifestyle behaviors in children with obesity living in Verona, Italy: a longitudinal study // Obesity. 2020; 28: 1382-1385. [https://doi.org/10.1002/oby.22861].

18. Gvozdenko T. A., Cherpak N. A., Volkova M. V., Belik L. A. Socio-economic aspects of restorative treatment of patients with respiratory pathology / Trudy NII meditsinskoy klimatologii i vosstanovitel'nogo lecheniya. Vladivostok: DVFU, 2014. P. 6-18.

19. Zaytsev A. A., Chernov S. A., Kryukov Ye. V. s soavt. Practical experience in managing patients with a new coronavirus infection COVID-19 in a hospital (preliminary results and recommendations) // The Lechaschi Vrach Journal. 2020; 6: 74-79.

20. Zuykova A. A., Krasnorutskaya O. N., Kotova Yu. A. s soavt. The effectiveness of the inclusion of sodium deoxyribonucleate at the stage of medical aftercare of patients with community-acquired pneumonia // The Lechaschi Vrach Journal. 2020; 6: 80-84.]

21. Zuykova A. A., Bugrimov D. Yu., Krasnorutskaya O. N. s soavt. Practical experience in the application of programs for the rehabilitation treatment of patients after COVID-19 in outpatient medical organizations // The Lechaschi Vrach Journal. 2020; 12: 54-61.

22. Makarova N. I., Tsygina T. Yu., Makarova A. V. s soavt. The results of healthimproving treatment of patients who have undergone a new coronavirus infection COVID-19 in a phthisiopulmonological sanatorium // Meditsinskiy al'yans. 2020; 3 (8): 15-24.

23. Zuykova A. A., Krasnorutskaya O. N., Bugrimov D. Yu. The effectiveness of the implementation of rehabilitation treatment programs for patients with COVID-19 / Sbornik trudov kongressa – XXX Natsional'nyy kongress po boleznyam organov dykhaniya. M., 2020. Р. 54.

24. Filatov O. Yu., Nazarov V. A. Pattern-recognizing receptors of innate immunity and their role in immunotherapy (review) // Patogenez. 2020; 18 (4): 4-15.

25. Stefano B., Bruno B., Ilaria P. Low physical functioning and impaired performance of activities of daily life in COVID-19 patients who survived hospitalization // Spruit European Respiratory Journal. 2020; 56: 2002096. DOI: 10.1183/13993003.02096-2020/.

26. Bohannon R. W., Crouch R. 1-Minute sit-to-stand test: systematic review of procedures, performance, and clinimetric properties // J Cardiopulm Rehabil Prev. 2019; 39: 2-8. DOI: 10.1097/ HCR.0000000000000336.

27. Halpin S. J., McIvor. C., Whyatt G. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation // J. Med. Virol. 2021; 93: 1013-1022. https://doi.org/10.1002/jmv.26368.